Efficacy and Safety of Levemir® Used as Basal Insulin

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2

Treatments: Drug: insulin aspart; Drug: insulin detemir

Study type: Observational

Funder types: Industry

Identifiers

NCT01548248

NN304-1928

Details and patient eligibility

About

This study is conducted in Europe. The aim of this study is to evaluate efficacy and safety of insulin detemir (Levemir®) used as basal insulin on the glycaemic control, weight and incidence of hypoglycaemic events in insulin treated subjects with type 1 or type 2 diabetes treated with insulin NPH under normal clinical practice conditions in Slovakia.

Enrollment: 631 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Type 1 or type 2 diabetes treated with insulin NPH

Trial design

631 participants in 1 patient group

Levemir® users

Treatment:

Drug: insulin aspart

Drug: insulin detemir